Rolin L. Wade

880 total citations
80 papers, 637 citations indexed

About

Rolin L. Wade is a scholar working on Economics and Econometrics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rolin L. Wade has authored 80 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Economics and Econometrics, 15 papers in Surgery and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rolin L. Wade's work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Lipoproteins and Cardiovascular Health (11 papers) and Medication Adherence and Compliance (10 papers). Rolin L. Wade is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (18 papers), Lipoproteins and Cardiovascular Health (11 papers) and Medication Adherence and Compliance (10 papers). Rolin L. Wade collaborates with scholars based in United States, United Kingdom and Switzerland. Rolin L. Wade's co-authors include Chi‐Chang Chen, Catherine B. McGuiness, Jeetvan Patel, Pallavi Rane, Brian H. Nathanson, Victoria Divino, Mitch DeKoven, Jaime L. Natoli, David J. Harrison and Robert J. Taylor and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rolin L. Wade

79 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rolin L. Wade United States	15	133	105	86	83	70	80	637
Allison Petrilla United States	13	126 0.9×	67 0.6×	75 0.9×	97 1.2×	28 0.4×	45	739
C McLeod United Kingdom	16	95 0.7×	123 1.2×	134 1.6×	93 1.1×	18 0.3×	27	835
Eric M. Tichy United States	14	103 0.8×	85 0.8×	50 0.6×	25 0.3×	45 0.6×	40	615
S Vasoo Singapore	15	167 1.3×	61 0.6×	46 0.5×	75 0.9×	20 0.3×	29	915
Eva Montané Spain	14	45 0.3×	89 0.8×	41 0.5×	106 1.3×	147 2.1×	40	746
Ilan Feldhamer Israel	16	74 0.6×	29 0.3×	43 0.5×	104 1.3×	58 0.8×	45	759
Hélène Théophile France	15	39 0.3×	71 0.7×	52 0.6×	32 0.4×	42 0.6×	28	602
Jean‐Paul Fagot France	16	64 0.5×	152 1.4×	72 0.8×	31 0.4×	98 1.4×	23	1.6k
Francisco Ortega Spain	16	114 0.9×	151 1.4×	67 0.8×	14 0.2×	42 0.6×	32	816
Jean‐Pierre Wauters Switzerland	16	81 0.6×	143 1.4×	32 0.4×	62 0.7×	111 1.6×	45	1.0k

Countries citing papers authored by Rolin L. Wade

Since Specialization

Citations

This map shows the geographic impact of Rolin L. Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolin L. Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolin L. Wade more than expected).

Fields of papers citing papers by Rolin L. Wade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolin L. Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolin L. Wade. The network helps show where Rolin L. Wade may publish in the future.

Co-authorship network of co-authors of Rolin L. Wade

This figure shows the co-authorship network connecting the top 25 collaborators of Rolin L. Wade. A scholar is included among the top collaborators of Rolin L. Wade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolin L. Wade. Rolin L. Wade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khatib, Rasha, et al.. (2023). Lipid-Lowering Therapy Utilization and Dosage Among Patients with Acute Coronary Syndrome Events: A Retrospective Cohort from 12 Community Hospitals. Clinical Epidemiology. Volume 15. 547–557. 2 indexed citations

Coyle, Patricia K., et al.. (2023). Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 78. 104881–104881. 2 indexed citations

Camargo, Carlos A., Pallavi Rane, Andrew F. Beck, et al.. (2023). Geographic variation in disease burden among patients with severe persistent asthma in the United States. Annals of Allergy Asthma & Immunology. 132(5). 602–609.e4. 2 indexed citations

Xu, Xiaoqing, et al.. (2022). Medical management patterns in a US commercial claims database following a nontraumatic fracture in postmenopausal women. Archives of Osteoporosis. 17(1). 92–92. 2 indexed citations

McGuiness, Catherine B., et al.. (2021). Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials. Rheumatology and Therapy. 8(2). 793–802. 2 indexed citations

Wade, Rolin L., et al.. (2020). Changes in Acute Migraine-specific Medications After Initiating Erenumab: Results from a Real-world Retrospective Cohort Study in the United States (1685). Neurology. 94(15_supplement). 4 indexed citations

Aguilar, David, et al.. (2020). PRO103 REASSESSMENT OF A REAL-WORLD POPULATION OF ADULTS WITH TYPE 2 DIABETES (T2D): WHEN LOW LEVELS OF C-PEPTIDE OR PRESENCE OF DIABETES AUTOANTIBODIES MIGHT INDICATE POSSIBLE TYPE 1 DIABETES (T1D). Value in Health. 23. S348–S348. 1 indexed citations

Ding, Yao, et al.. (2019). <p>Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment</p>. Patient Preference and Adherence. Volume 13. 1927–1939. 19 indexed citations

McGuiness, Catherine B., et al.. (2019). PMU106 EVALUATING THE ABILITY OF A MOBILE MEDICATION APP TO IMPROVE ADHERENCE IN A CHRONICALLY NON-ADHERENT POPULATION IN HYPERTENSION, DIABETES AND DEPRESSION. Value in Health. 22. S268–S268. 1 indexed citations

10.

Stolshek, Bradley S., et al.. (2018). Two-year adherence and costs for biologic therapy for rheumatoid arthritis.. PubMed. 24(8 Spec No.). SP315–SP321. 11 indexed citations

11.

Baum, Seth J., Chi‐Chang Chen, Pallavi Rane, et al.. (2018). CARDIOVASCULAR RISK IN PATIENTS DENIED ACCESS TO PCSK9I THERAPY. Journal of the American College of Cardiology. 71(11). A1760–A1760. 6 indexed citations

12.

Chen, Chi‐Chang, et al.. (2018). Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients. Therapeutics and Clinical Risk Management. Volume 14. 2425–2435. 2 indexed citations

13.

Divino, Victoria, et al.. (2017). Assessing the impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategies on opioid prescription volume. Journal of Opioid Management. 13(3). 157–168. 7 indexed citations

14.

Divino, Victoria, et al.. (2016). Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007–13) and prospective (2014–18) MIDAS sales data analysis. Orphanet Journal of Rare Diseases. 11(1). 68–68. 13 indexed citations

15.

Taitel, Michael, et al.. (2016). Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy. Population Health Management. 19(6). 454–461. 33 indexed citations

16.

Wade, Rolin L., et al.. (2015). Impact of a pharmacist medication adherence consultation program on health care costs and risk of hospitalization. Value in Health. 18(3). A3–A3. 1 indexed citations

17.

Shortridge, Emily, et al.. (2015). Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan. International Journal of Clinical Practice. 69(7). 783–790. 4 indexed citations

18.

Ben‐Joseph, Rami, et al.. (2014). Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans. Journal of Medical Economics. 17(10). 708–718. 4 indexed citations

19.

Wade, Rolin L., et al.. (2012). 847. Critical Care Medicine. 40. 1–328. 1 indexed citations

20.

Gorman, Kathleen M., Karen Boaz, Rolin L. Wade, & Ross M. Miller. (2012). PHP24 Employee Medication Adherence: Pharmacy Claims Analysis of an Employer-Sponsored Onsite Health Center. Value in Health. 15(4). A17–A17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact